# Indee Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/indee-labs

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.indeelabs.com
- Total disclosed funding: $3.9M
- Latest round: Seed (Oct 1, 2020)
- Investors on record: 6

## About

Based in California, US, and founded in 2015 by Ryan Pawell (CEO), Indee Labs is a biotechnology company specializing in developing gene delivery hardware that employs microfluidic vortex shedding. In April 2023, Indee Labs raised venture funding from BroadOak Capital Partners and DeciBio Ventures.

Indee Labs is the creator of an intracellular delivery system that does not rely on viruses and is designed to deliver nucleic acids, proteins, and gene-editing complexes. In addition, the company sells instruments that use microfluidic vortex shedding or microscopic turbulence to gently deliver macromolecules, nucleic acids, and gene-editing complexes to various cell types. The Hydropore technology allows researchers to develop gene-modified cell therapies more efficiently and on a larger scale.

The company plans to use the April 2023 funding to accelerate the development and launch of Hydropore for cell therapy research, clinical development, and commercial manufacturing.

## Funding rounds

- Seed, Oct 1, 2020 — Pioneer Fund
- Seed, May 17, 2018, $2.6M — Founders Fund, Social Capital, Main Sequence Ventures
- Angel, Jul 3, 2017, $1.3M — Y Combinator, SOSV

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Angel
- SOSV (https://capitalatlas.ai/funds/sosv) — Angel
- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Seed
- Social Capital (https://capitalatlas.ai/funds/social-capital) — Seed
- Main Sequence Ventures (https://capitalatlas.ai/funds/main-sequence-ventures) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed